Showing results (1301-1310 of 2,354) with videos related to
Sort By:
Pageof 236
Critical Pathways in Cardiology|May 13, 2011
Updating the chest pain algorithm: incorporating new evidence on emerging antiplatelet agentsBenjamin Z Galper, Jennifer Stant, Mireya Reilly, et al.Journal of the American College of Cardiology|April 1, 1997
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial InvestigatorsG W Stone, C L Grines, D Rothbaum, et al.The American Journal of Cardiology|January 25, 2011
Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial)Vivian G Ng, Alexandra J Lansky, James B Hermiller, et al.Arquivos Brasileiros De Cardiologia|January 19, 2002
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trialL A Mattos, C L Grines, J E Sousa, et al.American Heart Journal|April 13, 2004
Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trialAbhiram Prasad, Gregg W Stone, Eve Aymong, et al.Anesthesia and Analgesia|January 22, 2025
The Association of the Coronavirus Disease-2019 Pandemic With Disparities in Maternal OutcomesLaurent G Glance, Karen E Joynt Maddox, J Christopher Glantz, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 28, 2013
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial)Dariusz Dudek, Roxana Mehran, Artur Dziewierz, et al.American Heart Journal|October 8, 2013
Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trialSorin J Brener, Jose M Dizon, Roxana Mehran, et al.JACC. Cardiovascular Interventions|January 11, 2020
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes From the BIONICS and NIREUS TrialsMaayan Konigstein, Pieter C Smits, Michael P Love, et al.Circulation. Cardiovascular Interventions|August 23, 2023
Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-AnalysisToshiki Kuno, Atsuyuki Watanabe, Satoshi Shoji, et al.Pageof 236